Clinical trial

Mega-CHOEP: Conventional Chemo Vs HD Chemo Followed by Auto SCT in Younger Pts…

NCT00129090 · German High-Grade Non-Hodgkin's Lymphoma Study Group, Other · Completed

Key facts

NCT number NCT00129090
Title Mega-CHOEP: Conventional Chemo Vs HD Chemo Followed by Auto SCT in Younger Pts With Aggressive Non-Hodgkin's Lymphoma
Official title A Randomized Phase III Study to Compare Conventional Chemotherapy (CHOEP-14) + Rituximab vs High-dose Chemotherapy Followed by Autologous Stem Cell Transplantation (Mega-CHOEP-21) + Rituximab in Younger Patients With Aggressive NHL
Lead sponsor German High-Grade Non-Hodgkin's Lymphoma Study Group, Other
Collaborators Deutsche Krebshilfe e.V., Bonn (Germany)
Status Completed
Phase Phase 3
Study type Interventional
Conditions Non-Hodgkin's Lymphoma (NHL)
Intervention type Drug
Interventions R-CHOEP 14 with 12x Rituximab
Enrollment 450
Start date Mar 1, 2003
Primary completion Oct 1, 2014
Completion Oct 1, 2017
First posted Aug 11, 2005
Last update posted May 25, 2023
Countries Germany

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies